We are live on ! Find out more
AIM

Arcadia Investment Management Portfolio holdings

AUM $584M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+8.37%
1 Year Est. Return
+21.44%
3 Year Est. Return
+83.48%
5 Year Est. Return
+113.71%
10 Year Est. Return
+434.1%
AUM
$532M
AUM Growth
+$32.5M
Cap. Flow
+$5.64K
Cap. Flow %
0%
Top 10 Hldgs %
30.33%
Holding
318
New
36
Increased
68
Reduced
83
Closed
25

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$1.68M
2
AAPL icon
Apple
AAPL
+$955K
3
TMO icon
Thermo Fisher Scientific
TMO
+$775K
4
AVGO icon
Broadcom
AVGO
+$715K
5
ICE icon
Intercontinental Exchange
ICE
+$659K

Sector Composition

Rank Sector Weight
1 Technology 25.91%
2 Healthcare 16.2%
3 Consumer Discretionary 11.01%
4 Financials 8.82%
5 Industrials 8.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
226
Lockheed Martin
LMT
$139B
$26K ﹤0.01%
68
+18
+36% +$6.92K
PLTR icon
227
Palantir
PLTR
$421B
$26K ﹤0.01%
1,000
FSTX
228
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$26K ﹤0.01%
3,000
CMA
229
DELISTED
Comerica
CMA
$24K ﹤0.01%
330
DGRW icon
230
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.3B
$24K ﹤0.01%
400
VTRS icon
231
Viatris
VTRS
$18.7B
$24K ﹤0.01%
1,645
-1,907
-54% -$27.6K
MJ icon
232
Amplify Alternative Harvest ETF
MJ
$105M
$23K ﹤0.01%
93
+10
+12% +$2.52K
CLB icon
233
Core Laboratories
CLB
$561M
$22K ﹤0.01%
576
-99
-15% -$3.55K
KARS icon
234
KraneShares Electric Vehicles and Future Mobility Index ETF
KARS
$80.9M
$22K ﹤0.01%
+465
New +$19.8K
DIS icon
235
Walt Disney
DIS
$178B
$21K ﹤0.01%
117
+9
+8% +$1.62K
IR icon
236
Ingersoll Rand
IR
$33.6B
$21K ﹤0.01%
434
+170
+64% +$8.34K
OGN icon
237
Organon & Co
OGN
$3.58B
$20K ﹤0.01%
+650
New +$21.4K
ARCC icon
238
Ares Capital
ARCC
$14.3B
$18K ﹤0.01%
900
DNP icon
239
DNP Select Income Fund
DNP
$4.09B
$18K ﹤0.01%
1,766
T icon
240
AT&T
T
$165B
$18K ﹤0.01%
828
-471
-36% -$10.7K
GDL
241
GDL Fund
GDL
$91.9M
$17K ﹤0.01%
1,900
-1,400
-42% -$12.6K
MDT icon
242
Medtronic
MDT
$114B
$17K ﹤0.01%
+134
New +$16.8K
UNH icon
243
UnitedHealth
UNH
$371B
$16K ﹤0.01%
+41
New +$16.3K
RPT
244
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$16K ﹤0.01%
1,200
CRM icon
245
Salesforce
CRM
$162B
$15K ﹤0.01%
60
+43
+253% +$9.91K
DWX icon
246
State Street SPDR S&P International Dividend ETF
DWX
$529M
$15K ﹤0.01%
385
FCF icon
247
First Commonwealth Financial
FCF
$2.17B
$14K ﹤0.01%
978
ROK icon
248
Rockwell Automation
ROK
$48.3B
$13K ﹤0.01%
+45
New +$12.1K
AMG icon
249
Affiliated Managers Group
AMG
$9.6B
$12K ﹤0.01%
75
-25
-25% -$3.99K
IWN icon
250
iShares Russell 2000 Value ETF
IWN
$14.5B
$12K ﹤0.01%
75

Similar funds

Arcadia Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Arcadia Investment Management held 318 positions worth $532M, up 6.5% from $499M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Arcadia Investment Management's Q2 2021 filing shows 36 new, 68 increased, 83 reduced and 25 closed positions. Its largest new stake was Arch Resources, Inc.: 126,326 shares worth $126K. The largest sale was Adobe, an estimated $1.68M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Arcadia Investment Management's largest Q2 2021 buy was Arch Resources, Inc.: 126,326 shares worth $126K.
  • Arcadia Investment Management added most to Vanguard Short-Term Corporate Bond ETF in Q2 2021, an estimated $1.89M increase.
  • Arcadia Investment Management's biggest Q2 2021 reduction was Adobe, cutting an estimated $1.68M.
  • Arcadia Investment Management fully exited Sprott Physical Silver Trust in Q2 2021, selling an estimated $145K.
  • Arcadia Investment Management's ten largest holdings make up 30% of its $532M portfolio in Q2 2021.
  • Arcadia Investment Management opened 36 new positions and closed 25 in Q2 2021.
  • Arcadia Investment Management's portfolio value rose 6.5% quarter-over-quarter to $532M.

Based on Arcadia Investment Management's 13F filing for Q2 2021, filed 2 Aug 2021.